Boston recalls faulty bare-metal stent technology
This article was originally published in Clinica
Boston Scientific has recalled thousands of units of a bare-metal carotid stent system due to a defect that could lead to potential patient injury. A notice posted on the FDA website yesterday revealed that on June 6, Boston had warned doctors about to stop using the NexStent system as the tip of the delivery system could detach during a procedure, potentially causing vessel wall injury or stroke.
You may also be interested in...
Alere’s professional diagnostics business helped the firm record overall revenue growth in the fourth quarter of 2010, offsetting a fall in influenza-based sales in North America.
Integra LifeSciences has gained exclusive worldwide rights from Stout Medical to develop and commercialise an expandable interbody fusion device.
Gen-Probe recently launched its Panther automated molecular diagnostics system in Europe with the aim of bringing another dimension to its product portfolio. Joseph Harvey met the firm’s CEO, Carl Hull, at the launch of the product in Frankfurt to find how high the firm has set its sights in the molecular diagnostics sector and how it is going to achieve its goals